Table 1.
Species | Target Pathogen/Antigen | Genetic Engineering Approach | Administration Via and Adjuvant Used | Key Findings | Reference |
---|---|---|---|---|---|
C. reinhardtii | Human papillomavirus A modified version of the E7 oncoprotein |
Stable, Chloroplast | s.c./QuilA | Elicited humoral responses and reduced tumor development |
[179] |
Schizochytrium sp. | H1N1 influenza virus Hemagglutinin |
Stable, Nuclear | Parenteral/Alone or plus Addavax (squalene-based) |
Induced humoral responses and complete immunoprotection upon a pathogen challenge | [180] |
Schizochytrium sp. | Zika virus Chimeric protein based on the LTB carrier and 3 epitopes from the E protein |
Transient | Oral/LTB s.c./Freund’s |
The algae-made antigen elicited humoral responses in mice following oral immunization, whose magnitude equals the response induced by s.c. immunization | [183] |